The Startup
Published in

The Startup

Machine Learning X Drug Discovery : The Nexus of Computational Biology


On average it takes 10–20 years to develop a drug and costs 0.5 to 2.6 billion dollars 🤯. Drugs that do pass the pre-clinical trials phase have a success rate in clinical trials of only 6.2%. That is the worst part. Companies and institutions invest all this time and capital into a drug only for it to fail in phase III trials.




Get smarter at building your thing. Follow to join The Startup’s +8 million monthly readers & +756K followers.

Recommended from Medium

Is Gene Editing In Its Prime?

First human trials of CRISPR outside China have been declared successful

What We Need To Know About Gene Therapy and Genetic Modification

Cloud Computing in Biology: 5 Programs You Need to Know

Investing in the Microbiome

A novel cancer vaccine shows great promise as it heads to human trials

DNA and the bell curve

Researchers treat brain tumors using ‘neutrobots’ in animal trials

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Aaron Lewis

Aaron Lewis

17 year-old AI and human longevity enthusiast

More from Medium

Teaching Insights: Improving Classroom Instruction through Insights for Faculty

What Is Negative Learning — and How to Avoid It?

Visualizing Corporate Plunder of the Canada Emergency Wage Subsidy with Bullet Charts

Failure to Forecast (Well)